Organization type


  • Academic research institution

Optimization phases


  • In vivo animal models (including assay/model development and testing)
  • Medicinal chemistry programs for hit to lead and lead optimization

Terapeutic areas


  • Cancer
  • Infectious diseases
  • Nervous Central System
  • Rare diseases

Additional activities


  • Consulting services
  • CROs providing no-regulatory and regulatory services for drug discovery
  • Industry associations